Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
September 2022
EMJ Cardiology 10 [Supplement 5] 2022
Highlighting a presentation that took place as part of the European Society of Cardiology’s (ESC) Heart Failure 2022 congress, this article summarised data on the efficacy and safety of aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM).
First malaria vaccine granted WHO prequalification
The World Health Organization (WHO) has granted the first prequalification for a malaria vaccine to GSK’s Mosquirix in an important step toward immunising children against the disease.
1
Mins
6th September 2022
EMJ announces partnership with the World Telehealth Initiative
EMJ is joining forces with the World Telehealth Initiative to support their mission to provide sustainable medical expertise through volunteer physicians…
Meet GOLD’s new catalyst – medical aficionado Juby Jacob-Nara
An exclusive version of our conversation Juby Jacob-Nara (Sanofi) about how former physicians can empower themselves to succeed in the pharmaceutical industry.
5th September 2022
Latest updates in Advanced Systemic Mastocytosis from EHA 2022
Latest updates in Advanced Systemic Mastocytosis from EHA 2022. Targeting systemic mastocytosis. Update in Haematology session EHA 2022, Prof. Olivier Hermine introduces the session on overcoming the challenges in diagnosis and management of advanced systemic macrocytosis.
6
Mins
5th September 2022
COVID-19 and Antimicrobial Resistance
For decades, infectious disease and public health experts have recognised antimicrobial resistance (AMR) and resulting infections due to multidrug resistant organisms as a persistent and increasingly urgent threat to public health at the local, national, and global level.
Driving post-conference motivation in pharma: a how-to guide
How can pharma embrace post-conference momentum?
11
Mins
2nd September 2022
Gene Therapy in Haemophilia: Updates from Clinical Trials and Insights to Future Technologies
At the International Society on Thrombosis and Haemostasis (ISTH) 2022 Congress, held 9th–13th July, multiple oral and poster presentations were dedicated to gene therapy as a treatment for haemophilia A or B.
September 2022
EMJ Hematology 10 [Supplement 5] 2022
This article covers multiple oral and poster presentations dedicated to gene therapy as a treatment for haemophilia A and B, which took place at the International Society on Thrombosis and Haemostasis (ISTH) Congress, 9th–13th July 2022.
2nd September 2022
Driving Dermatology Research
This week, Jonathan sits down with Robert Dellavalle, Professor of Dermatology, Colorado School of Medicine, Aurora, USA.
←
1
2
3
…
234
235
236
237
238
239
240
…
897
898
899
→